5 June 2018 - While a handful of drug companies say their average net prices have dropped, FDA Commissioner Scott Gottlieb announces a plan to encourage drug competition in the face of monopolies.

Drugmakers and regulators continue their theatrics about prices, but the end result for the consumer remains unclear.

Sanofi, Merck and Johnson & Johnson want you to know they dropped drug prices last year. The FDA, meanwhile, has said it plans to cut down on drug monopolies to help others lower their prices too.

The moves come after President Trump last month ran out a number of concepts to drive prices down that didn't involve going after drug companies but rather focused on shaming the companies into wanting to decrease medication prices. The issue of drug pricing undoubtedly will become higher profile as midterm elections grow near.

Read The Street article